期刊文献+

siRNA表达载体对乙酰肝素酶基因有效序列的筛选 被引量:2

Screening of effective sequence of heparanase gene-targeted by small interfering RNA
下载PDF
导出
摘要 目的:根据基因库中的人乙酰肝素酶(HPSE)基因序列,构建针对乙酰肝素酶基因的小干扰RNA(siRNA)及其表达载体,转染人乳腺癌MDA-MB-231细胞后观察其对HPSE基因的干扰作用。方法:设计HPSE靶向的发夹状siRNA,合成两条互补的寡核苷酸链(共4对),退火后连接入pG-PU6/GFP/Neo载体,转化后进行序列鉴定,脂质体转染MDA-MB-231细胞株,免疫蛋白印迹(West-ernblot)检测细胞蛋白质的表达。结果:设计出4条针对HPSE的siRNA,将退火后的双链寡核苷酸片段克隆到pGPU6/GFP/Neo载体,经过阳性菌落酶切鉴定与测序,结果正确,并通过脂质体转染方法转染到MDA-MB-231细胞株,Westernblot检测细胞蛋白质的表达明显降低。结论:成功构建了针对HPSE基因的siRNA载体,转染MDA-MB-231细胞后,HPSE蛋白的表达降低,其中HPSE-A和HPSE-B可明显抑制HPSE的表达。 Objective: According to heparanase’s gene sequence of gene bank, to construct heparanase gene-targeted small interfering RNA (siRNA)and its expression vector and to observe its interfering effect on the expression of heparanase gene in human malignant breast cancer MDA-MB-231 cells. Methods: Heparanase gene-targeted hairpin siRNA was designed, two complementary oligonucleotide strand was synthesized and inserted into pGPU6/GFP/Neo vector,which was identified by sequence identify. Human malignant breast cancer MDA-MB-231 cells were transfected with the constructed vector with lipofectamine method. Western blot was per-formed to evaluate the expression of heparanase protein. Results: Four kinds of heparanase gene-targeted hairpin siRNA were designed, and were inserted into pGPU6/GFP/Neo vector after annealing. The vector containing siRNA was proved to be right by sequencing. The result of Western blot indicated that the expression of heparanase could be degraded by siRNA. Conclusion: The expression of heparanase can be degraded by siRNA method, and HPSE-A and HPSE-B showed the best results.
出处 《中国现代普通外科进展》 CAS 2010年第2期93-96,共4页 Chinese Journal of Current Advances in General Surgery
基金 南京军区"十一五"科研规划重点课题(2007081)
关键词 RNA干扰 乙酰肝素酶 MDA-MB-231细胞 转染 RNA interference·Heparanase·MDA-MB-231 cells·Transfection
  • 相关文献

参考文献12

  • 1Sanderson RD,Yang Y,Suva LJ,et al.Heparan sulfate proteoglycans and heparanase-partners in osteolytic turner growth and metastasis[J].Matrix Biol,2004,23(6):341-352.
  • 2Vlodavsky I,Ilan N,Nadir Y,et al.Heparanase,heparin and the coagulation system in cancer progression[J].Thromb Res,2007,120(Suppl 2):s112-120.
  • 3Ilan N,Elkin M,Vlodavsky I.Regulation,function and clinical significance of heparanase in cancer metastasis and angiogenesis[J].Int J Biochem Cell Biol,2006,38(12):2018-2039.
  • 4Ben-Zaken O,Shafat I,Gingis-Velitski S,et al.Low and high affinity receptors mediate cellular uptake of heparanase[J].Int J Biochem Cell Biol,2008,40(3):530-542.
  • 5Cohen I,Pappo O,Elkin M,et al.Heparanase promotes growth,angiogenesis and survival of primary breast tumors[J].Int J Cancer,2006,118(7):1609-1617.
  • 6Rohloff J,Zinke J,Schoppmeyer K,et al.Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma[J].Br J Cancer,2002,86(8):1270-1275.
  • 7Kelly T,Miao HQ,Yang Y,et al.High heparanase activity in multiple myeloma is associated with elevated microvessel density[J].Cancer Res,2003,63(24):8749-8756.
  • 8Shinyo Y,Kodama J,Hongo A,et al.Heparanase expression is an independent prognostic factor in patients with invasive cervical cancer[J].Ann Oncol,2003,14(10):1505-1510.
  • 9C(o)tte M and Yip GW.Heparanase,hyaluronan,and CD44 in cancers:a breast carcinoma perspective[J].Cancer Res,2006,66(21):10233-10237.
  • 10Mikami s,Ohashi K,Katsube K,et al.Coexpression of heparanase,basic fibroblast growth factor and vascular endothelial growth factor in human esophageal carcinomas[J].Pathol Int,2004,54(8):556-563.

二级参考文献10

  • 1Mahadevan D, Bearss D J, Vankayalapati H, Structure-based design of novel anti-cancer agents targeting aurora kinases[ J]. Curr Med Chem Anticancer Agents, 2003, 3 ( 1 ) : 25-34.
  • 2Hamada M, Yakushijin Y, Ohtsuka M, et al. Aurora2/BTAK/STK15 is involved in cell cycle checkpoint and cell survival of aggressive non-Hodgkins lymphorna[ J ]. Br J Haematol, 2003, 121 (3) : 439-447.
  • 3Plasterk RH. RNA silencing: The genome's immune system[J]. Science, 2002, 269(5571 ) : 1263-1265.
  • 4Hannon GJ. RNA interference[J]. Nature, 2002, 418(6894): 244-251.
  • 5Cerutti H. RNA interference: Traveling in the cell and gaining functions? [J]. Trends Genet, 2003, 19(1): 39-46.
  • 6Bischoff JR, Aanderson L, Zhu Y, et al. A homologue of drosophila aurora kinase is oncogenie and amplified in human colorectal cancers[ J]. EMBO J, 1998, 17 ( 11 ) : 3052-3065.
  • 7Durerere S, Descamps S, Priget C. On the role of aurora-A in centrosome function[ J]. Oncogene, 2002, 21 (40) : 6175-6183.
  • 8Salcakura C, Hagiwara A, Yasooka R, et al. Tumour-amplified kinase BTAK is amplified and overexpression in gastric cancers with possible involvement in aneuploid fomation[ J]. Br J Cancer,2001, 84(6) : 824-831.
  • 9Li D, Zhu J, Firozi PF, et al. Overexpression of oncogenie STK15/BTAK/Aurora-A kinase in human pancreatic cancer[ J].Clin Cancer Res, 2003, 9(3): 991-997.
  • 10Gritsko TM, Coppla C, Paciga JE, et al. Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer[J]. Clie Cancer Res, 2003, 9(2) : 1420-1426.

共引文献1

同被引文献21

  • 1黄庆,田辉,李林,梁飞.乙酰肝素酶与肿瘤关系的研究进展[J].现代诊断与治疗,2006,17(3):160-163. 被引量:1
  • 2Kadenhe-Chiweshe A, Papa J, MeCrudden KW, et al. Sustained VEGF blockade results in microenvironmental sequestration of VEGF by tumors and persistent VEGF receptor-2 activation. Mol Cancer Res ,2008,6:77-82.
  • 3Kelly T, Suva LJ, Nicks KM,et al. Tumor-derived syndecan-I medi- ates distal cross-talk with bone that enhances osteoclastogenesis. J Bone Miner Res ,2010,25 : 1295-1304.
  • 4Theodoro TR, de Matos LL, Sant Anna AV,et al. Heparanase expres- sion in circulating lymphocytes of breast cancer patients depends on the presence of the primary tumor and/or systemic metastasis. Neopla- sia,2007,9:504-510.
  • 5Barry M, Cahill RA, Roche-Nagte G, et al. Neoplasms escape selcctive COX-2 inhibition in an animal model of breast cancer. Ir J Med Sci, 2009,178 : 201-208.
  • 6Zhu J, Yao X. Use of DNA methylation for cancer detection promises and challenges [J]. Int J Bioehem Cell Biol, 2009, 41(1) : 147-154.
  • 7De Smet C,Loriot A. DNA hypomethylation in cancer [J]. Epi- genetics,2010,5(3) :206-213.
  • 8Sharrard RM,Royds JA,Rogers S. Patterns of methylation of the c-myc gene in human eolorectal cancer progression [J]. Br J Cancer, 1992,65(5) : 667-672.
  • 9Szyf M. DNA methylation machinery as a target for anticancer therapy[J]. Pharmacol Ther, 1996,70(1) : 1-17.
  • 10Szyf M, Pakneshan P, Rabbani SA. DNA demethylation and cancer therapeutic implications[J]1. Cancer Lett, 2004,211 (2) 133-143.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部